| Dec'19 | Dec'18 | Dec'17 | Sep'16 | Sep'15 | Sep'14 | Sep'13 | Sep'12 | Sep'11 |
|---|---|---|---|---|---|---|---|---|
Cash Flows From Operating Activities: | ||||||||
Net Income (Loss) Attributable to Parent | ||||||||
-996,500 | -3,607,000 | 2,134,400 | 643,700 | 324,700 | -319,300 | 58,800 | 134,600 | 150,700 |
(Income) loss from discontinued operations, net of income taxes | ||||||||
- | - | - | - | - | - | - | -6,700 | -6,300 |
Income from continuing operations | ||||||||
- | - | - | - | - | - | - | 141,300 | 157,000 |
Adjustments to reconcile net cash from operating activities: | ||||||||
Depreciation and amortization | ||||||||
951,100 | 852,100 | 808,300 | 834,500 | 672,500 | 275,900 | 139,600 | 130,900 | 119,800 |
Share-based compensation | ||||||||
33,800 | 34,600 | 59,200 | 42,900 | 117,000 | 67,700 | 16,200 | 10,700 | 10,300 |
Deferred income taxes | ||||||||
-604,300 | -541,500 | -1,744,100 | -432,900 | -191,600 | -107,500 | -9,000 | 9,000 | 36,400 |
Non-cash impairment charges | ||||||||
388,000 | 3,893,100 | 63,700 | 16,900 | 0 | 381,200 | 0 | 0 | - |
Inventory provisions | ||||||||
18,000 | 37,900 | 34,100 | 29,200 | 0 | 32,100 | 15,500 | 2,700 | - |
Losses on divestiture | ||||||||
-33,500 | 800 | 418,100 | 95,300 | 0 | 0 | - | - | - |
Gains on debt extinguishment, net | ||||||||
466,600 | 8,500 | 8,300 | - | - | - | - | - | - |
Other non-cash items | ||||||||
65,700 | 42,400 | 13,100 | -29,600 | 25,500 | 23,600 | 6,200 | 13,400 | 11,400 |
Changes in assets and liabilities, net of the effects of acquisitions: | ||||||||
Accounts receivable, net | ||||||||
-31,600 | -145,800 | 16,200 | -31,200 | -700 | 51,300 | 181,200 | 6,800 | -700 |
Inventories | ||||||||
23,100 | 63,100 | 23,600 | 17,300 | -61,300 | -56,000 | -27,700 | 62,800 | -12,200 |
Accounts payable | ||||||||
6,700 | 24,600 | -25,800 | -9,700 | 20,400 | -32,900 | 7,200 | -8,300 | 4,600 |
Income taxes | ||||||||
-2,100 | 99,000 | -34,200 | 93,900 | 30,200 | -54,800 | 60,700 | 79,400 | 36,000 |
Increase (decrease) Opioid-related litigation settlement liability | ||||||||
1,600,000 | 0 | 0 | - | - | - | - | - | - |
Accrued and other liabilities | ||||||||
- | - | - | - | - | - | - | -38,700 | -3,500 |
Other | ||||||||
161,500 | 5,500 | 89,000 | -17,900 | 79,200 | -149,900 | -6,600 | -11,800 | -8,100 |
Net Cash From Operating Activities | ||||||||
742,900 | 665,500 | 727,300 | 1,184,600 | 930,500 | 373,400 | 135,900 | 255,800 | 370,200 |
Cash Flows From Investing Activities: | ||||||||
Capital expenditures | ||||||||
133,000 | 127,000 | 186,100 | 182,900 | 148,000 | 127,800 | 147,900 | 144,200 | 120,400 |
Acquisitions, net of cash acquired | ||||||||
0 | 699,900 | 76,300 | 245,400 | 2,154,700 | 2,793,800 | 88,100 | 13,200 | 0 |
Proceeds from divestitures, net of cash | ||||||||
95,100 | 313,000 | 576,900 | 266,700 | 0 | 0 | - | - | - |
Restricted cash | ||||||||
- | - | - | - | - | -4,100 | 0 | 0 | - |
Purchase of product rights | ||||||||
- | - | - | - | - | - | - | - | 0 |
Other | ||||||||
-29,600 | 33,600 | -3,900 | -6,000 | -3,000 | -26,700 | -1,300 | -5,200 | -7,800 |
Net Cash From Investing Activities | ||||||||
-8,300 | -480,300 | 318,400 | -155,600 | -2,299,700 | -2,890,800 | -234,700 | -152,200 | -112,600 |
Cash Flows From Financing Activities: | ||||||||
Issuance of external debt | ||||||||
695,000 | 690,300 | 1,465,000 | 98,300 | 3,010,000 | 3,043,200 | 898,100 | 0 | 0 |
Repayment of external debt | ||||||||
945,100 | 1,693,600 | 917,200 | 568,600 | 1,848,400 | 34,800 | 1,300 | 1,300 | 1,300 |
Excess tax benefit from share-based compensation | ||||||||
- | - | - | - | - | 8,900 | 3,400 | 1,700 | 1,800 |
Debt financing costs | ||||||||
10,100 | 12,100 | 12,700 | 100 | 39,900 | 71,700 | 12,000 | 0 | 0 |
Net transfers to parent | ||||||||
- | - | - | - | - | - | 515,900 | 104,000 | 258,100 |
Proceeds from exercise of share options | ||||||||
600 | 1,000 | 4,100 | 14,000 | 34,400 | 25,800 | 600 | 0 | 0 |
Repurchase of shares | ||||||||
2,600 | 57,500 | 651,700 | 652,900 | 92,200 | 17,500 | 0 | 0 | - |
Other | ||||||||
-17,900 | -23,100 | -17,700 | -53,000 | -28,100 | 0 | 100 | 0 | 0 |
Net Cash Provided From Financing Activities | ||||||||
-280,100 | -1,095,000 | -130,200 | -1,162,300 | 1,035,800 | 2,953,900 | 373,000 | -103,600 | -257,600 |
Effect of currency rate changes on cash | ||||||||
600 | -1,800 | 2,500 | 300 | -11,600 | -4,200 | 1,300 | 0 | 0 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ||||||||
455,100 | -911,600 | 918,000 | -133,000 | -345,000 | 432,300 | 275,500 | 0 | 0 |
Supplemental Disclosures of Cash Flow Information: | ||||||||
Cash paid for interest | ||||||||
314,200 | 309,700 | 339,100 | 332,400 | 200,500 | 57,200 | 800 | 600 | 600 |
Cash paid for income taxes, net | ||||||||
30,700 | 12,400 | 73,400 | 165,400 | 123,800 | 128,000 | 15,000 | 4,900 | 11,600 |